Efficient liposomal encapsulation
Details for Australian Patent Application No. 2003205048 (hide)
International Classifications
Event Publications
17 July 2003 Complete Application Filed
Priority application(s): 60/346,287 09.01.02 US
4 September 2003 Application Open to Public Inspection
Published as AU-B-2003205048
12 May 2005 Assignment before Grant
Elan Pharmaceuticals, Inc. The application has been assigned to Transave, Inc.
29 January 2009 Amendment Made
The nature of the amendment is: Amend the name of the co-inventor from Tong, Shangguan to Shangguan, Tong
26 February 2009 Application Accepted
Published as AU-B-2003205048
25 June 2009 Standard Patent Sealed
4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003205049-Efficient nucleic acid encapsulation into medium sized liposomes
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser